Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
Saved in:
Main Authors: | John C Morris, Susan L Stark, Rebecca M Bollinger, Audrey Keleman, Regina Thompson, Elizabeth Westerhaus, Anne M Fagan, Tammie LS Benzinger, Suzanne E Schindler, Chengjie Xiong, David Balota, Beau M Ances |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/48f5aaf10d1c432faa119e41b4653dbe |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease
by: Stephan Müller, et al.
Published: (2017) -
Where We Fall Down: Tensions in Teaching Social Medicine and Global Health
by: Amy Finnegan, et al.
Published: (2017) -
Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease
by: Kathryn Goozee, et al.
Published: (2017) -
Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature
by: Samuel Asanad, et al.
Published: (2021) -
Disease progression modelling from preclinical Alzheimer’s disease (AD) to AD dementia
by: Soo Hyun Cho, et al.
Published: (2021)